Defining therapeutic compound potential
The Challenge A biotech company specialising in therapeutic antibodies wanted to assess the potential of a lead compound in a novel disease indication. They needed to mine public single‑cell RNA‑sequencing datasets to evaluate target gene expression and understand...
Omics‑driven diagnostics in companion animals
The Challenge A leading animal health company had amassed large volumes of molecular data and needed to develop diagnostics for target disease in cats and dogs. They faced challenges in managing, integrating and extracting value from thousands of proteomic, genomic...
Enhancing drug development through AI & data management
The Challenge A mid‑sized biotech company had invested heavily in data management but was not realising sufficient value. Leadership wanted an assessment of the entire data landscape to identify opportunities for AI‑driven improvements across the drug‑development...